Caudate lobe-sparing subtotal hepatectomy as treatment for extensive intrahepatic arterioportal fistula

作     者：Rui Tang Guang-Dong Wu Ang Li Li-Han Yu Xuan Tong Jun Yan Qian Lu Rui Tang;Guang-Dong Wu;Ang Li;Li-Han Yu;Xuan Tong;Jun Yan;Qian Lu

作者机构：Hepatopancreatobiliary CenterBeijing Tsinghua Changgung HospitalSchool of Clinical MedicineInstitute for Precision MedicineTsinghua UniversityBeijing 102218China 

出 版 物：《Hepatobiliary & Pancreatic Diseases International》 (国际肝胆胰疾病杂志（英文版）)

年 卷 期：2023年第22卷第4期

页      面：409-411页

核心收录：

学科分类：1002[医学-临床医学] 100210[医学-外科学(含：普外、骨外、泌尿外、胸心外、神外、整形、烧伤、野战外)] 10[医学] 

基　　金：supported by a grant from the National Natural Science Foundation of China(81930119) 

主　　题：treatment chemotherapy arterial 

摘      要：Intrahepatic arterioportal fistulas(APFs)are abnormal hepatic artery and portal vein(PV)communications that develop as a result of congenital malformation,trauma,ruptured hepatic aneurysm,cirrhosis,tumor-related changes,biopsy,chemotherapy or iatrogenic causes[1,2].The most common symptoms are gastrointestinal bleeding and ascites secondary to portal hypertension;other symptoms include abdominal pain,pyrexia,edema,back pain and jaundice[3].The main goal of therapy is to decrease the portal pressure with variceal bleeding being the absolute indi-cation for surgical *** embolization(TAE)should be the first choice to treat APFs,while resection,portocaval shunt and even transplantation may cure APFs in the case of TAE failure[4].In previous reports,caudate lobe-sparing subtotal hep-atectomy(CLSSH)has been applied for the treatment of primary hepatolithiasis and hepatocellular carcinoma[5,6].As far as we know,this is the first report describing CLSSH as treatment for an extensive intrahepatic APF,which involved segments 2 to 8,with corresponding hypertrophy of the caudate lobe.